Quest Diagnostics (NYSE:DGX) Raised to Buy at Wall Street Zen
Wall Street Zen upgraded shares of Quest Diagnostics (NYSE:DGX – Free Report) from a hold rating to a buy rating in a research note issued to investors on Friday. Other equities research analysts have also recently issued research reports about the company. Redburn Partners set a $195.00 price objective on Quest Diagnostics in a research […]
Wall Street Zen upgraded shares of Quest Diagnostics (NYSE:DGX – Free Report) from a hold rating to a buy rating in a research note issued to investors on Friday. Other equities research analysts have also recently issued research reports about the company. Redburn Partners set a $195.00 price objective on Quest Diagnostics in a research […]
